Titan Biotech Limited announced unaudited standalone earnings results for third quarter and nine months ended Dec. 31, 2015. For the quarter, the company reported net sales/income from operations of INR 115.107 million, profit from operations before other income, finance costs & exceptional items of INR 7.290 million, profit before tax of INR 6.816 million, net profit of INR 4.268 million or INR 0.55 per basic and diluted share compared to the net sales/income from operations of INR 83.041 million, profit from operations before other income, finance costs & exceptional items of INR 5.993 million, profit before tax of INR 6.134 million, net profit of INR 4.05 million or INR 0.52 per basic and diluted share for the same quarter a year ago.

For the year to date, the company reported net sales/income from operations of INR 331.801 million, profit from operations before other income, finance costs & exceptional items of INR 24.008 million, profit before tax of INR 19.563 million, net profit of INR 12.271 million or INR 1.59 per basic and diluted share compared to the net sales/income from operations of INR 283.536 million, profit from operations before other income, finance costs & exceptional items of INR 21.966 million, profit before tax of INR 18.431 million, net profit of INR 12.167 million or INR 1.57 per basic and diluted share for the same period a year ago.